FFA
ELDN icon

Farther Finance Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History

Farther Finance Advisors’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.15K Sell
453
-184
-29% -$618 ﹤0.01% 5546
2026
Q2 		$2.5K Buy
637
+598
+1,533% +$2.17K ﹤0.01% 5096
2026
Q1 		$117 Buy
+39
New +$92 ﹤0.01% 5493

Other funds holding ELDN

EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
BAM
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

Farther Finance Advisors's ELDN Position: Q3 2026 in Review

Farther Finance Advisors reduced its Eledon Pharmaceuticals (ELDN) stake by 29% in Q3 2026, selling an estimated $618 and leaving 453 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #5546.

Farther Finance Advisors first reported a position in ELDN in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.5K in Q2 2026. 7 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • Farther Finance Advisors held 453 shares of Eledon Pharmaceuticals worth $1.15K as of Q3 2026.
  • Farther Finance Advisors sold 184 Eledon Pharmaceuticals shares in Q3 2026, an estimated $618.
  • Eledon Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5546 holding.
  • Farther Finance Advisors first reported a position in Eledon Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Farther Finance Advisors's Eledon Pharmaceuticals position peaked at $2.5K in Q2 2026.
  • 7 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.